CD9 and cancer: Besides, while EVEpCAM-CD9 can be released from different types of epithelial cancers and the diagnostic performance of uEVEpCAM-CD9 in these cancers remains poorly investigated, further large-scale studies will be warranted to fully evaluate the potential applications of uEVEpCAM-CD9 with regard to the diagnosis of varieties of cancers.